Summit Therapeutics

$1.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 4:00 PM EDT today
$0.00 (0.00%) Today

Why Robinhood?

You can buy or sell SMMT and other stocks, options, ETFs, and crypto commission-free!

About SMMT

Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Read More Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.

Employees
61
Headquarters
Abingdon, Oxfordshire
Founded
2004
Market Cap
40.44M
Price-Earnings Ratio
1.26
Dividend Yield
Average Volume
36.62K
High Today
$1.27
Low Today
$1.27
Open Price
$1.27
Volume
200.00
52 Week High
$2.50
52 Week Low
$1.10

Collections

SMMT Earnings

-$0.53
-$0.21
$0.10
$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Sep 19, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.